Document Detail


Is pregnancy safe after uterine artery embolisation?
MedLine Citation:
PMID:  22329577     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Please cite this paper as: Kitson S, Macphail S, Bulmer J. Is pregnancy safe after uterine artery embolisation? BJOG 2012; DOI: 10.1111/j.1471-0528.2012.03286.x.
Authors:
Sj Kitson; S Macphail; J Bulmer
Related Documents :
12094077 - Hydrocephalus manifestation in the genetic polydactyly/ arhinencephaly mouse (pdn/pdn).
3179387 - Evidence for the presence of oxytocin in the ovine epididymis.
9393477 - Tissue response to suture materials implanted subcutaneously in a rabbit model.
16077147 - Estimating total urea removal and protein catabolic rate by monitoring uv absorbance in...
8855447 - Oxidative stress and the fetotoxicity of alcohol consumption during pregnancy.
18774567 - Sublingual misoprostol after surgical management of early termination of pregnancy.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-14
Journal Detail:
Title:  BJOG : an international journal of obstetrics and gynaecology     Volume:  -     ISSN:  1471-0528     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100935741     Medline TA:  BJOG     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2012 RCOG.
Affiliation:
Department of Obstetrics and Gynaecology, Royal Victoria Hospital, Newcastle-upon-Tyne Department of Pathology, Royal Victoria Hospital, Newcastle-upon-Tyne, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The perils of overprotective parenting: fathers' perspectives explored.
Next Document:  Novel targeted system to deliver chemotherapeutic drugs to EphA2-expressing cancer cells.